Akèy › Tit travay › Clinical Data Manager
Clinical Data Manager: Salè H-1B
322 aplikasyon kondisyon travay te itilize tit travay Clinical Data Manager. Salè baz medyàn ofri $96,042; mwatye mitan $83,972–$111,966.
Demann (LCA)322
Salè medyan ofri$96,042
Mwatye salè yo$83,972–$111,966
10yèm–90yèm pousantaj$74,412–$128,128
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|
| PVR Technologies, Inc. | 33 | $93,000 |
| Nexpro Technologies, Inc | 27 | $94,328 |
| TruMinds Technologies Inc | 24 | $92,518 |
| Statminds, LLC | 13 | $90,000 |
| Calsoft Labs Inc | 12 | $119,142 |
| Arcane Systems Inc | 10 | $88,000 |
| Stacklogy Inc | 6 | $83,517 |
| TK-Chain LLC | 6 | $84,132 |
| Katalyst Healthcares & Life Sciences Inc. | 5 | $111,966 |
| Swarn, Inc. | 5 | $111,966 |
| HealthVerity, Inc. | 5 | $124,530 |
| Intellectt, Inc. | 4 | $102,482 |
| Eficens Systems Inc | 4 | $86,000 |
| R3 Technology Inc | 4 | $126,277 |
| Vanda Pharmaceuticals Inc. | 4 | $92,500 |
| Inductive Quotient Analytics Inc | 4 | $92,928 |
| Alliancechicago | 3 | $82,342 |
| TS Global Solutions LLC | 3 | $93,600 |
| Advance Research Institute Inc. | 3 | — |
| Apex Technology Systems Inc | 3 | $110,240 |
| Globex Healthcare & Pharma Inc. | 3 | $98,155 |
| KPC HQ, LLC | 3 | $93,590 |
| Cristcot Management Company Inc. | 3 | $156,000 |
| United Pharma Technologies, Inc. | 2 | $104,000 |
| Verily Life Sciences LLC | 2 | $121,000 |
| Devoir Software Solutions LLC | 2 | $86,000 |
| KPC Global Management, LLC | 2 | $88,256 |
| NYC Gravitynet LLC | 2 | $91,666 |
| Unicon Sciences Inc | 2 | $102,482 |
| COD Research USA Inc. | 2 | $120,000 |
| Shionogi, Inc. | 2 | $117,500 |
| DeltaMed Solutions Inc. | 2 | $130,000 |
| Vimalraj, Inc. | 2 | $68,000 |
| Tekorion Inc. | 2 | $90,000 |
| Technofy IT Solutions LLC | 2 | $99,934 |
| Olympus Corporation of the Americas | 2 | $139,437 |
| eteraflexconnects, LLC | 2 | $81,354 |
| SystImmune, Inc. | 2 | $145,494 |
| Roche Sequencing Solutions, Inc. | 2 | $142,500 |
| Amarex Clinical Research, LLC | 2 | $83,438 |
| Suvoda LLC | 2 | $146,000 |
| Destin IT Solutions INC | 2 | $110,000 |
| Biorasi LLC | 2 | $130,000 |
| Vakula Technologies Inc. | 2 | $79,456 |
| H&S Enterprise New York Inc | 2 | — |
| AR Infotek Solutions LLC | 2 | $112,434 |
| Denali Therapeutics Inc. | 1 | $179,878 |
| Virtual Reality Kingdom Technologies, LLC | 1 | $127,650 |
| K3-Innovations, Inc. | 1 | $114,400 |
| Splint Pharma LLC | 1 | $89,898 |
| IQVIA RDS Inc. | 1 | $130,000 |
| Synergy Global Systems Inc | 1 | $99,486 |
| Sanctimonia Solutions LLC | 1 | $98,000 |
| Param Technologies Inc | 1 | $81,000 |
| Oakland Physical Therapy and Rehab, Inc | 1 | $90,106 |
| Omeros Corporation | 1 | $115,000 |
| Spectrosys Solutions Inc | 1 | $97,739 |
| Stellar IT Solutions LLC | 1 | $74,880 |
| Roche Molecular Systems, Inc. | 1 | $110,088 |
| Alcon Research, LLC | 1 | $80,267 |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|
| Nivo I (antre) | $80,850 |
| Nivo II (kalifye) | $98,000 |
| Nivo III (eksperyans) | $120,000 |
| Nivo IV (plen kompetans) | $131,338 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|
| FY2023 | 81 | $93,600 |
| FY2024 | 79 | $90,000 |
| FY2025 | 86 | $100,000 |
| FY2026 | 50 | $103,000 |
Vil yo
- King of Prussia, PA12
- Frisco, TX8
- McKinney, TX7
- South Plainfield, NJ7
- Austin, TX7
- Princeton, NJ7
- Charlotte, NC6
- Paramus, NJ6
- Chicago, IL5
- South San Francisco, CA5
- Irving, TX5
- Philadelphia, PA5
- Plano, TX4
- Morrisville, NC4
- Iselin, NJ4
- New York, NY4
- Piscataway, NJ4
- Alameda, CA4
- Houston, TX4
- Macomb, IL4
- Alpharetta, GA4
- Somerset, NJ3
- Basking Ridge, NJ3
- Leander, TX3
- Englewood, CO3
- Zephyrhills, FL3
- Jersey City, NJ3
- Celina, TX3
- Cary, NC3
- Parsippany, NJ3
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).